Trial Details
RECRUITINGBasic Information
| Clinical ID | c39 |
|---|---|
| Identifier | NCT07310095 |
| Trial Title | A Study to Evaluate the Efficacy of Guselkumab in Chinese Participants With Crohn's Disease (CD) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Guselkumab (GUS) |
Participant Information
| Sponsor | Xian-Janssen Pharmaceutical Ltd. |
|---|---|
| City | Guangzhou |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2025-12-30 |
|---|---|
| Primary Completion Date | 2027-09-15 |
| Completion Date | 2027-11-15 |